US EditionRussia Claims that New Cancer Vaccine Has 100% Efficacy and Safety in Clinical Trials
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.3 Articles
3 Articles
Russia Set To Launch Personalized mRNA Cancer Vaccine
Russia is creating a personalized mRNA cancer vaccine and intends to begin treating patients in October 2025. The vaccine, EnteroMix, was developed using technology similar to that of the COVID-19 mRNA vaccines. “The vaccine uses AI-driven algorithms to create individualized mRNA blueprints based on patient genetic data, reducing development time from months to hours,” MedPath stated. “The Russian EnteroMix cancer vaccine is now ready for clinic…
The vaccine called Entromix trains the immune system to recognize and destroy cancer cells • Researchers reported success in preclinical trials
Russia claims that new cancer vaccine has 100% efficacy and safety in clinical trials
Russia has claimed that they have developed a new vaccine that could see cancer cured once and for all.Veronika Skvortsova, the head of the Russian Federal Medical-Biological Agency (FMBA), shared the news at the Eastern Economic Forum (EEF) in Vladivostok, per Russian news agency TASS.According to Skvortsova, the research took several years, with the last three years focusing on mandatory preclinical studies.She stated: "The vaccine is now read…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
